Clinical Trial

Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Following Bariatric Surgery

Study acronym: PHENOBEQOL73
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to identify pre-operative phenotypic determinants predictive of quality of life trajectories in post-bariatric surgery patients. In addition, this study will have as a secondary objective the highlighting of a potential link between post-surgery quality of life trajectories and those of anxiety/depression scores, eating behaviors and body mass indices. This study will be conducted during the usual care of patients undergoing the GEROM73 program, lasting a total of 30 months. The GEROM73 program includes care for the six months preceding bariatric surgery and the 24 months following surgery. This program supports patients throughout their bariatric care.. Throughout the GEROM73 program, patients will complete questionnaires on anxiety, depression, eating disorders, Impact of Weight on Quality Of Life. Patients' weight, body mass index and body schema will also be measured throughout the GEROM program.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-23; most recent amendment 2026-06-09.
Status change: Not Yet Recruiting → Recruiting 2026-06-09
Trial Details
NCT Number NCT06951893
Lead Sponsor Centre Hospitalier Metropole Savoie
Conditions Obesity, Morbid, Obesity and Overweight, Bariatric Surgery, Bariatric Surgery Patients, Bariatric Surgery Patient, Bariatric Surgery (Sleeve Gastrectomy ), Bypass, Gastric
Enrollment 165 participants
Start Date 2025-06-17
Primary Completion 2030-09-09 (estimated)
Study Completion 2030-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-06-10